Lab Insights - Archives - Page 2 of 4 Immunoassay

Evidence-based medicine in heart failure: insights from Prof David Sim

August 3, 2021

Prof David Sim, Director of the Clinical and Translational Research office of Singapore’s National Heart Centre, has extensive experience in heart failure evaluation and guiding management through the use of cardiac biomarkers. In this talk at the 7th annual China Conference on Laboratory Technology and Application (CCLTA), Prof Sim discusses the immense clinical value of […]

Evidence-based medicine in heart failure: insights from Prof David Sim Read More »

COVID-19 antibody testing in the post-vaccine era

July 12, 2021

With the advent of vaccines against the SARS-CoV-2 virus, the COVID-19 pandemic entered a new phase. In a recent webinar hosted by Roche Diagnostics Asia Pacific, two leading laboratory experts discussed how testing strategies may evolve in the post-vaccine era, including the changing role of antibody testing. Here are some of the key takeaways. Combination

COVID-19 antibody testing in the post-vaccine era Read More »

HPV screening and vaccination in Asia: overcoming barriers to access

June 14, 2021

Cervical cancer is the 4th leading type of cancer amongst women in the world. Caused by human papillomavirus (HPV) infection, cervical cancer is highly preventable through the use of prophylactic measures like HPV vaccines and robust screening programmes. Through the launch of the Global Strategy to Accelerate the Elimination of Cervical Cancer in late 2020,

HPV screening and vaccination in Asia: overcoming barriers to access Read More »

Liver disease in Asia Pacific: insights from Prof Pierce Chow

May 24, 2021

Liver disease in Asia Pacific: Q&A with Prof Pierce Chow

In this Q&A, Prof Pierce Chow of the National Cancer Centre Singapore discusses the epidemiology of liver disease in Asia Pacific; key considerations around the clinical management of common liver diseases like HBV, HCV, fatty liver and HCC; and the critical role of diagnostics in ensuring early detection and effective treatment. [00:09] – Prof Chow’s

Liver disease in Asia Pacific: insights from Prof Pierce Chow Read More »

HCV elimination in Pakistan: insights from Dr Zaigham Abbas

April 30, 2021

This article is part of a series of hepatitis C (HCV) elimination in Pakistan and other high-risk countries around the world. Forthcoming articles in this series will cover the Pakistani provinces of Sindh and Punjab. Scroll to the bottom of the article for the full list. Hepatitis C virus (HCV) is a major public health

HCV elimination in Pakistan: insights from Dr Zaigham Abbas Read More »

HCV screening in Egypt: key elements of a successful national screening programme

March 19, 2021

This article is part of a series on hepatitis C (HCV) elimination in Pakistan and other high-risk countries around the world. Forthcoming articles in this series will cover the Pakistani provinces of Sindh and Punjab. Scroll to the bottom of the article for the full list. Hepatitis C virus (HCV) infection is one of the world’s

HCV screening in Egypt: key elements of a successful national screening programme Read More »

China viewpoint: fourth-generation HIV testing brings big benefits

January 18, 2021

Screenshot of china viewpoint 4th generation HIV testing brings big benefits talk

Early detection of HIV infection can facilitate timely interventions that improve treatment outcomes and prevent further transmission. Fourth-generation HIV tests, which simultaneously detect both HIV antibodies and p24 antigens, allow healthcare practitioners to detect the virus with greater speed and accuracy than more traditional approaches. In China, clinical guidelines and laboratory processes are evolving to

China viewpoint: fourth-generation HIV testing brings big benefits Read More »

Serum tumour markers and the future of cancer care: China’s viewpoint from the clinic and the lab

December 22, 2020

As the global burden of cancer increases every year, oncology professionals are seeking targeted, precise and sensitive methods to identify tumours and monitor their growth. For over a decade, many have used serum tumour markers (STM) as part of their diagnostic toolkit. To better understand how STMs are currently used and what the future holds

Serum tumour markers and the future of cancer care: China’s viewpoint from the clinic and the lab Read More »

Serum biomarkers in lung cancer care: updates from Dr Anand Sachithanadan

September 20, 2020

Serum biomarkers in lung cancer diagnostics: updates from Dr Anand Sachithanadan

What is the role of serum biomarkers in lung cancer care and how is it changing? Dr Anand Sachithanadan, a consultant cardiothoracic surgeon with appointments at Sunway Medical and Subang Jaya Medical Centre Malaysia, provides key updates in this recent webinar hosted by Roche Diagnostics Asia Pacific. “There’s been a growing interest over the last

Serum biomarkers in lung cancer care: updates from Dr Anand Sachithanadan Read More »

IL-6 shows promise for COVID-19 management in Asia Pacific

August 31, 2020

In the ongoing fight against the COVID-19 pandemic, many healthcare systems are adding interleukin-6 (IL-6) to their diagnostic toolkit. An early predictor of severe COVID-19, IL-6 is an ideal prognostic biomarker because it can be detected from an easily accessible biological source (serum or plasma) and via well-characterised, rapid assay systems. A growing body of

IL-6 shows promise for COVID-19 management in Asia Pacific Read More »